NutriBand (NTRB) Accounts Payables (2016 - 2026)
NutriBand's (NTRB) quarterly Accounts Payables came in at $502654.0 in Q1 2026, down 28.07% year-on-year from $698821.0 in Q1 2025, and down 16.95% quarter-over-quarter from $605209.0 in Q4 2025.
NutriBand (NTRB) Accounts Payables (2016 - 2026) Analysis & Trends
NutriBand has disclosed Accounts Payables across 11 years of filings, most recently posting $502654.0 for Q1 2026.
- Accounts Payables for Q1 2026 came in at $502654.0, down 28.07% year-over-year; the trailing twelve-month figure through Jan 2026 was $502654.0 (down 28.07% YoY), and the FY2026 annual result was $502654.0, down 28.07% from the prior year.
- Accounts Payables came in at $502654.0 for Q1 2026 at NutriBand, down from $605209.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.4 million in Q3 2025 to a low of $387862.0 in Q4 2023.
- The 5-year median for Accounts Payables is $620861.0 (2022), against an average of $680078.8.
- Across the five-year window, Accounts Payables sank 38.74% in 2022 and jumped 130.02% in 2024, its largest moves.
- NutriBand's Accounts Payables stood at $535841.0 in 2022, then declined by 27.62% to $387862.0 in 2023, then surged by 130.02% to $892154.0 in 2024, then plunged by 32.16% to $605209.0 in 2025, then declined by 16.95% to $502654.0 in 2026.
- The last three Accounts Payables figures came in at $502654.0 (Q1 2026), $605209.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 502,654.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 502,654.00 |
| Oct 31, 2025 | 605,209.00 |
| Jul 31, 2025 | 1.39 Mn |
| Apr 30, 2025 | 721,671.00 |
| Jan 31, 2025 | 698,821.00 |
| Oct 31, 2024 | 892,154.00 |
| Jul 31, 2024 | 778,827.00 |
| Apr 30, 2024 | 994,106.00 |
| Jan 31, 2024 | 680,132.00 |
| Oct 31, 2023 | 387,862.00 |
| Jul 31, 2023 | 496,778.00 |
| Apr 30, 2023 | 543,753.00 |
| Jan 31, 2023 | 534,679.00 |
| Oct 31, 2022 | 535,841.00 |
| Jul 31, 2022 | 620,861.00 |
| Apr 30, 2022 | 535,440.00 |
| Jan 31, 2022 | 639,539.00 |
| Oct 31, 2021 | 644,543.00 |
| Jul 31, 2021 | 975,596.00 |
| Apr 30, 2021 | 873,988.00 |